Cholangiocarcinoma: all 930 studies
Page 7 of 10. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder CancerStatus unknownNCT04333927Phase 2
- A Novel Patient Engagement Platform Among Patients With Gastrointestinal MalignanciesCompletedNCT04316078Not applicable
- Neoadjuvant Gemcitabine Plus Cisplatin with or Without Durvalumab in Resectable Biliary Tract CancerActive, not recruitingNCT04308174Phase 2
- Chemotherapy mFOLFIRINOX in Locally Advanced or Metastatic CholangiocarcinomaStatus unknownNCT04305288
- Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide DimerTerminatedNCT04304781Phase 1
- Clinical Effect and Safety of PDT and RFA for Unresectable EHCCCompletedNCT04301999Not applicable
- DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract CancerActive, not recruitingNCT04298021Phase 2
- PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After SurgeryActive, not recruitingNCT04295317Phase 2
- Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative TreatmentCompletedNCT04264260Phase 2
- Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 RearrangementCompletedNCT04256980Phase 2
- Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention StudyStatus unknownNCT04243057
- A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene FusionCompletedNCT04238715Phase 2
- Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)Active, not recruitingNCT04238637Phase 2
- Safety and Tolerability of ABM-1310 in Patients With Advanced Solid TumorsTerminatedNCT04190628Phase 1
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsCompletedNCT04157985Phase 3
- National Translational Science Network of Precision-based Immunotherapy for Primary Liver CancerCompletedNCT04145141
- Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorApproved for marketingNCT04100694
- Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic AlterationsNo longer availableNCT04087876
- Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic CholangiocarcinomaStatus unknownNCT04077983Phase 2
- Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal CancersTerminatedNCT04077372Not applicable
- Study of TRIFLURIDINE/TIPIRACIL in Previously Treated CholangiocarcinomaTerminatedNCT04076761Phase 2
- Surgery for Recurrent Intrahepatic CholangiocarcinomaCompletedNCT04072250
- Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesActive, not recruitingNCT04068194Phase 1/2
- Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With CholangiocarcinomaCompletedNCT04059562Phase 2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer PainStatus unknownNCT04014478Not applicable
- Long-term Morbidity After Surgery for Perihilar CholangiocarcinomaCompletedNCT03999593
- Study of TQB2450 Combined With Anlotinib in Subjects With Advanced CholangiocarcinomaStatus unknownNCT03996408Phase 1/2
- Study of Olaparib and Durvalumab in IDH-Mutated Solid TumorsActive, not recruitingNCT03991832Phase 2
- Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced CholangiocarcinomaStatus unknownNCT03982680Phase 2
- Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic CholangiocarcinomaStatus unknownNCT03951597Phase 2
- Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management StudyStatus unknownNCT03951324
- Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract CancerStatus unknownNCT03943043Phase 1/2
- Treatment of Advanced Intrahepatic CholangiocarcinomaStatus unknownNCT03940378Phase 3
- A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerCompletedNCT03929666Phase 2
- Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing CancerActive, not recruitingNCT03907852Phase 1/2
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary TumorsCompletedNCT03895970Phase 2
- A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsCompletedNCT03872947Phase 1
- Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts ImagesTerminatedNCT03852836Not applicable
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
- TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersCompletedNCT03829436Phase 1
- Lenvatinib for Unresectable Intrahepatic CholangiocarcinomaWithdrawnNCT03801499Phase 2
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract CancersActive, not recruitingNCT03801083Phase 2
- Routine Lymphadenectomy for Intrahepatic CholangiocarcinomaCompletedNCT03796819Not applicable
- Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's ProcedureStatus unknownNCT03792048Not applicable
- Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct TractStatus unknownNCT03788655
- A Study to Evaluate MIV-818 in Patients With Liver Cancer ManifestationsCompletedNCT03781934Phase 1/2
- Lenvatinib Plus PD-1 Antibody for Unresectable ICCSuspendedNCT03779100Phase 2
- Adjuvant Chemotherapy for Biliary Tract Cancer After Curative ResectionStatus unknownNCT03779035Phase 3
- Bilioenteric Anastomosis by Magnetic Compressive TechniqueStatus unknownNCT03774589Not applicable
- Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaStatus unknownNCT03772132Phase 2
- HAIC Versus Systemic Chemotherapy for Unresectable ICCStatus unknownNCT03771846Phase 3
- Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaStatus unknownNCT03768375Phase 2
- PTFE Stents for Treatment of Malignant Biliary StricturesStatus unknownNCT03763214Not applicable
- Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)Status unknownNCT03739164
- A Phase 1 Study of ZSP1241 in Participants With Advanced Solid TumorsStatus unknownNCT03734926Phase 1
- Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct CancerCompletedNCT03708445Not applicable
- Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct CancerCompletedNCT03679338Phase 2
- Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic CholangiocarcinomaStatus unknownNCT03633773Phase 1/2
- Fluorescence Image Guided Surgery in CholangiocarcinomaStatus unknownNCT03620292Phase 1/2
- Trastuzumab in HER2-positive Biliary Tract CancerCompletedNCT03613168Phase 2
- Neoadjuvant mFOLFOXIRI for Potentially Resectable CholangiocarcinomaStatus unknownNCT03603834Phase 2
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
- A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic CholangiocarcinomaStatus unknownNCT03521219Phase 2
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- Precise Treatment System of Biliary Malignancies Based on Special Disease DatabaseStatus unknownNCT03499782
- EUS Evaluation of CBD Diameter in Malignant Obstructive JaundiceCompletedNCT03494023
- SHR-1210 in Combination With GEMOX in Patients With Advanced BTCCompletedNCT03486678Phase 2
- Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation ProgramStatus unknownNCT03475966Not applicable
- Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA PatientsCompletedNCT03473574Phase 2
- Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer SurgeryStatus unknownNCT03447691Not applicable
- Fluorescence QRH-882260 Peptide Imaging in the Bile DuctCompletedNCT03438435Phase 1
- Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)No longer availableNCT03414489
- Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyCompletedNCT03405909
- Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar CholangiocarcinomaStatus unknownNCT03383796Not applicable
- A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaCompletedNCT03377179Phase 2
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Bortezomib in Intrahepatic Cholangiocellular CarcinomaStatus unknownNCT03345303Phase 3
- Multiorgan Metabolic Imaging Response Assessment of AbemaciclibCompletedNCT03339843Phase 2
- A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCompletedNCT03329950Phase 1
- RALPPS in Patients With Hilar and Intrahepatic CholangiocarcinomaCompletedNCT03320980
- Study of GNS561 in Patients With Liver CancerTerminatedNCT03316222Phase 1/2
- Stereotactic Body Radiation Therapy for Unresectable Perihilar CholangiocarcinomaCompletedNCT03307538Not applicable
- Margin Status After Pancreaticoduodenectomy for CancerCompletedNCT03267966Not applicable
- Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerActive, not recruitingNCT03257761Phase 1
- A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic CholangiocarcinomaCompletedNCT03251443Phase 2
- A Study of MGD013 in Patients With Unresectable or Metastatic NeoplasmsCompletedNCT03219268Phase 1
- Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary StricturesTerminatedNCT03211169Not applicable
- Combined HCC-MFCCCCompletedNCT03178409
- A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin TumorsTerminatedNCT03172832Not applicable
- RFA for Malignant Biliary ObstructionStatus unknownNCT03166436Not applicable
- Enteral Nutrition After PancreaticoduodenectomyCompletedNCT03150615Not applicable
- An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesTerminatedNCT03144661Phase 1
- Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .Status unknownNCT03140007Not applicable
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar CholangiocarcinomaStatus unknownNCT03132649
- Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by SurgeryWithdrawnNCT03117855Phase 1
- ncRNAs in Exosomes of CholangiocarcinomaStatus unknownNCT03102268